反応式
[C:1]([C:4]1[CH:5]=[CH:6][C:7]2[N:11]=[C:10]([CH3:12])[N:9]([CH2:13][C:14]3[N:15]=[CH:16][C:17]4[C:22]([CH:23]=3)=[CH:21][CH:20]=[CH:19][CH:18]=4)[C:8]=2[CH:24]=1)(O)=[O:2].[CH2:25]([S:30]([NH2:33])(=[O:32])=[O:31])[CH2:26][CH2:27][CH2:28][CH3:29]>CN(C)C=O>[CH:16]1[C:17]2[C:22](=[CH:21][CH:20]=[CH:19][CH:18]=2)[CH:23]=[C:14]([CH2:13][N:9]2[C:8]3[CH:24]=[C:4]([C:1](=[O:2])[NH:33][S:30]([CH2:25][CH2:26][CH2:27][CH2:28][CH3:29])(=[O:32])=[O:31])[CH:5]=[CH:6][C:7]=3[N:11]=[C:10]2[CH3:12])[N:15]=1参加物
実験手順
N,N′-carbonyldiimidazole (0.324 g) was added to a solution of 6-carboxy-1-(isoquinolin-3-ylmethyl)-2-methylbenzimidazole (0.413 g) as obtained in Production Example 5 in N,N-dimethylformamide (10 ml) all at once and the mixture was stirred at room temperature for 1.5 hour. Then, 1-pentanesulfonamide (0.302 g) and diazabicyclo-undecene (0.304 g) were added thereto, and the resulting mixture was stirred at 100° C. for 6.5 hour. The reaction solution was concentrated, brine was added to the concentrate, and the mixture was extracted with chloroform. The organic layer was concentrated and the residue was purified by silica gel column chromatography (eluate: methanol/chloroform=1/19) followed by recrystallization from hexane/ethyl acetate (2/3) to yield the desired compound, 1-(isoquinolin-3-ylmethyl)-2-methyl-6-(1-pentanesulfonyl-carbamoyl)benzimidazole (13) (0.142 g).
後処理
- stirringthe resulting mixture was stirred at 100° C. for 6.5 hour
- concentrationThe reaction solution was concentrated
- additionbrine was added to the concentrate
- extractionthe mixture was extracted with chloroform
- concentrationThe organic layer was concentrated
- customthe residue was purified by silica gel column chromatography (eluate: methanol/chloroform=1/19)
- customfollowed by recrystallization from hexane/ethyl acetate (2/3)
出典と根拠
- ORDレコード
- ord-2c97d0e2135741fa895f5966314f5042
- 出典データセット
- uspto-grants-2002_07
- 特許番号
- US06420409B1
関連ノート
読み込み中…